Hugo Biotech, a biotech company based in Beijing, has entered into a partnership with Watchmaker Genomics, a U.S.-based provider of innovative molecular analysis solutions, to collaborate in South Africa. The collaboration aims to combine their respective R&D strengths to develop more sensitive, user-friendly, and cost-effective infectious disease detection products. The two companies have also reached a preliminary agreement to promote Hugo Bio’s automated and intelligent solutions for pathogenic microorganisms across Africa. Financial details of the agreement were not disclosed.
Hugo Bio, established in 2017, is a pioneer in applying cell-free metagenomic next-generation sequencing (NGS) technology in clinical settings within China. Watchmaker Genomics, on the other hand, is recognized for its advanced enzymatic techniques that have led to breakthrough applications in DNA and RNA reading, writing, and editing. The company’s product pipeline includes precision enzymes and complete kits for next-generation sequencing, synthetic biology, and molecular diagnostic applications.- Flcube.com
